Sernova Biotherapeutics Inc
SVA.TO
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -95.82% | 73.26% | -80.66% | 18.74% | -41.09% |
| Total Receivables | -38.65% | 21.48% | 20.57% | -40.60% | -59.65% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -68.82% | 3.24% | 194.92% | -77.81% | 5.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -82.86% | 47.42% | -69.22% | 2.98% | -40.27% |
|
|
|||||
| Total Current Assets | -82.86% | 47.42% | -69.22% | 2.98% | -40.27% |
| Net Property, Plant & Equipment | -74.71% | -1.62% | -9.21% | -7.92% | -6.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -100.00% | -51.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.12% | 4.72% | -3.67% | -0.93% | -0.49% |
| Total Assets | -76.52% | 31.80% | -60.62% | 0.08% | -36.95% |
|
|
|||||
| Total Accounts Payable | 3.68% | -0.04% | 10.88% | -9.49% | 18.03% |
| Total Accrued Expenses | 15.43% | 46.98% | -78.32% | 403.73% | -28.77% |
| Short-term Debt | 6.84% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -43.16% | 9.54% | 0.82% | 3.85% | 4.16% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.34% | 18.75% | -1.07% | 1.70% | 15.90% |
|
|
|||||
| Total Current Liabilities | 4.34% | 18.75% | -1.07% | 1.70% | 15.90% |
| Long-Term Debt | 16.72% | -- | -- | -- | -- |
| Short-term Debt | 6.84% | -- | -- | -- | -- |
| Capital Leases | -92.08% | -2.40% | -9.52% | -6.25% | -5.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.14% | 22.33% | -1.26% | 1.50% | 15.26% |
|
|
|||||
| Common Stock & APIC | 0.07% | 5.21% | -3.21% | 2.50% | -0.13% |
| Retained Earnings | -2.39% | -7.27% | 0.07% | -2.51% | -4.94% |
| Treasury Stock & Other | -2.80% | 1,282.77% | -3.64% | -- | -- |
| Total Common Equity | -18.07% | -20.70% | -33.23% | -2.35% | -126.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.07% | -20.70% | -33.23% | -2.35% | -126.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.07% | -20.70% | -33.23% | -2.35% | -126.87% |
|
|
|||||